[go: up one dir, main page]

FI935318A0 - 15-deoxispergualinanaloger, foerfarande foer deras framstaellning samt deras anvaendning i terapi - Google Patents

15-deoxispergualinanaloger, foerfarande foer deras framstaellning samt deras anvaendning i terapi

Info

Publication number
FI935318A0
FI935318A0 FI935318A FI935318A FI935318A0 FI 935318 A0 FI935318 A0 FI 935318A0 FI 935318 A FI935318 A FI 935318A FI 935318 A FI935318 A FI 935318A FI 935318 A0 FI935318 A0 FI 935318A0
Authority
FI
Finland
Prior art keywords
deoxyspergual
amylated
analogues
derivatives
manufacture
Prior art date
Application number
FI935318A
Other languages
English (en)
Other versions
FI935318L (fi
FI112211B (fi
Inventor
Patrice Renaut
Luc Lebreton
Patrick Dutartre
Philippe Derrepas
Soth Samreth
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of FI935318A0 publication Critical patent/FI935318A0/fi
Publication of FI935318L publication Critical patent/FI935318L/fi
Application granted granted Critical
Publication of FI112211B publication Critical patent/FI112211B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
FI935318A 1992-12-02 1993-11-29 Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet FI112211B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9214517 1992-12-02
FR9214517A FR2698628B1 (fr) 1992-12-02 1992-12-02 Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Publications (3)

Publication Number Publication Date
FI935318A0 true FI935318A0 (fi) 1993-11-29
FI935318L FI935318L (fi) 1994-06-03
FI112211B FI112211B (fi) 2003-11-14

Family

ID=9436147

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935318A FI112211B (fi) 1992-12-02 1993-11-29 Menetelmä terapeuttisesti käyttökelpoisten 15-deoksispergualiinianalogien valmistamiseksi sekä menetelmässä käytettävät välituotteet

Country Status (24)

Country Link
US (1) US5476870A (fi)
EP (1) EP0600762B1 (fi)
JP (1) JP2945261B2 (fi)
KR (1) KR100187328B1 (fi)
CN (1) CN1045431C (fi)
AT (1) ATE140215T1 (fi)
AU (1) AU664124B2 (fi)
CA (1) CA2110437C (fi)
CZ (1) CZ284958B6 (fi)
DE (1) DE69303583T2 (fi)
DK (1) DK0600762T3 (fi)
ES (1) ES2092263T3 (fi)
FI (1) FI112211B (fi)
FR (1) FR2698628B1 (fi)
GR (1) GR3021269T3 (fi)
HK (1) HK1000467A1 (fi)
HU (1) HU218908B (fi)
NO (1) NO180483C (fi)
NZ (1) NZ250330A (fi)
RU (1) RU2114823C1 (fi)
SK (1) SK280286B6 (fi)
TW (1) TW311132B (fi)
UA (1) UA39920C2 (fi)
ZA (1) ZA938821B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE172189T1 (de) * 1995-02-10 1998-10-15 Fournier Ind & Sante 15-deoxyspergualin-analoge verbindungen, ihre verwendung als therapeutika und verfahren zu ihrer herstellung
FR2734263B1 (fr) * 1995-05-17 1997-06-20 Fournier Ind & Sante Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique
DE19728436A1 (de) * 1997-07-03 1999-01-07 Niels Franke Niedrigdosierte 15-Desoxyspergualin-Präparate
KR20010085742A (ko) * 1998-08-28 2001-09-07 추후제출 정밀한 길이의 폴리아미드 사슬, 그 제조방법 및 단백질결합체의 제조방법
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen
HUE036916T2 (hu) 2004-05-05 2018-08-28 Silence Therapeutics Gmbh Lipidek, lipid komplexek és ezek alkalmazása
CN101287497B (zh) 2004-12-27 2013-03-06 赛伦斯治疗公司 涂层脂质复合体和它们的用途
EP2269980A4 (de) 2008-12-24 2011-05-18 Vertex Closed Joint Stock Company Creatinamide, verfahren zu ihrer herstellung und wirkstoff zur ausführung einer neuroprotektiven aktion
RU2428414C2 (ru) 2009-11-03 2011-09-10 Закрытое Акционерное Общество "Вертекс" Способ получения амидов креатина
JP5878172B2 (ja) * 2010-07-29 2016-03-08 ラボラトワール フルニエ エスアーエス 炎症性眼疾患の治療/予防用化合物
FR2963238B1 (fr) * 2010-07-29 2012-12-28 Fournier Lab Sa Derives de 15-desoxyspergualine pour le traitement et/ou la prevention des maladies inflammatoires oculaires
KR101695730B1 (ko) 2015-03-10 2017-01-12 하경훈 마늘꼭지 절단기의 절단장치
FR3050455B1 (fr) * 2016-04-26 2019-06-14 Temisis Derives amides des acides polycafeoylquiniques, procede de preparation et utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
ES2039213T3 (es) * 1986-04-04 1993-09-16 Microbial Chemistry Research Foundation Procedimiento para producir nuevos compuestos relacionados con espergualina.
US5061787A (en) * 1988-06-24 1991-10-29 Nippon Kayaku Kabushiki Kaisha Novel spergualin-related compounds and compositions

Also Published As

Publication number Publication date
ZA938821B (en) 1994-06-30
GR3021269T3 (en) 1997-01-31
RU2114823C1 (ru) 1998-07-10
NO934338L (no) 1994-06-03
JPH06293728A (ja) 1994-10-21
TW311132B (fi) 1997-07-21
SK280286B6 (sk) 1999-11-08
HK1000467A1 (en) 1998-03-27
CZ262293A3 (en) 1994-06-15
DK0600762T3 (da) 1996-11-11
NO180483B (no) 1997-01-20
ES2092263T3 (es) 1996-11-16
FI935318L (fi) 1994-06-03
EP0600762A1 (fr) 1994-06-08
CN1045431C (zh) 1999-10-06
CN1095709A (zh) 1994-11-30
KR940014435A (ko) 1994-07-18
DE69303583D1 (de) 1996-08-14
EP0600762B1 (fr) 1996-07-10
SK135793A3 (en) 1994-06-08
FR2698628A1 (fr) 1994-06-03
AU664124B2 (en) 1995-11-02
HUT65782A (en) 1994-07-28
NO180483C (no) 1997-04-30
DE69303583T2 (de) 1996-11-21
CA2110437C (en) 1999-04-13
KR100187328B1 (ko) 1999-05-15
AU5188393A (en) 1994-06-16
CA2110437A1 (en) 1994-06-03
JP2945261B2 (ja) 1999-09-06
NZ250330A (en) 1995-06-27
HU218908B (hu) 2000-12-28
NO934338D0 (no) 1993-11-30
HU9303406D0 (en) 1994-03-28
UA39920C2 (uk) 2001-07-16
ATE140215T1 (de) 1996-07-15
US5476870A (en) 1995-12-19
CZ284958B6 (cs) 1999-04-14
FR2698628B1 (fr) 1995-02-17
FI112211B (fi) 2003-11-14

Similar Documents

Publication Publication Date Title
DK0580502T3 (da) 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse
FI935318A0 (fi) 15-deoxispergualinanaloger, foerfarande foer deras framstaellning samt deras anvaendning i terapi
MX9300433A (es) Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen.
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
ES2084225T3 (es) Derivados de salicil(tio)eter, procedimiento y productos intermedios para su obtencion.
ES2037666T3 (es) Utilizacion de las fenil-naftiridinas.
TW265347B (fi)
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
HU896173D0 (fi)
FI894653A0 (fi) Stabila oxapenem-3-karboxylsyror och deras anvaendning som b-laktamasfoerhindrare.
GR3022546T3 (en) Inositol phosphate analogues as calcium-antagonistic substances
ES2062214T3 (es) Derivados de aminooligohidroxi inhibidores de renina.
ES2095714T3 (es) Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen.
DK0472181T3 (da) 5-Amino-substituerede adenosinanaloge som immunsuppresiva
DK0552631T3 (da) Alfa-Aryl-alfa-hydroxy-beta-imidazolinyl-propionsyreamider
SE9203824D0 (sv) Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same
IL103855A0 (en) 5,6-dihydro-dibenz(b,e)azepin-6,11-dione-11-oximes,their preparation and pharmaceutical compositions containing them
FI924769A0 (fi) Foerfarande foer framstaellning av substituerade indoler
ATE23528T1 (de) +/- 2-((3,4-methylenedioxy)phenethyl)-5-((3carboxamido-4-hydroxy)-alpha-hydroxybenzyl)pyrrolidine, pharmazeutische zusammenstellungen die sie enthalten, verfahren zur herstellung und deren zwischenprodukte.
DE69108139D1 (de) Verwendung von 5'-Vinylhalo-aristeromycin/adenosin-Analoga als Immunsuppressiva.

Legal Events

Date Code Title Description
MA Patent expired